Sg Americas Securities, LLC Passage Bio, Inc. Transaction History

Sg Americas Securities, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 29, 2022	SELL	$1.63 - $3.46 $17,525 - $37,201	-10,752 Closed	0 $0
Q1 2022 Apr 29, 2022	SELL	$2.66 - $6.49 $14,100 - $34,403	-5,301 Reduced 33.02%	10,752 $33,000
Q4 2021 Feb 07, 2022	SELL	$6.24 - $10.2 $129,636 - $211,904	-20,775 Reduced 56.41%	16,053 $102,000
Q3 2021 Nov 01, 2021	BUY	$9.73 - $15.52 $282,500 - $450,607	29,034 Added 372.52%	36,828 $367,000
Q2 2021 Aug 12, 2021	BUY	$12.44 - $19.45 $3,607 - $5,640	290 Added 3.86%	7,794 $103,000
Q1 2021 May 13, 2021	BUY	$16.24 - $29.83 $121,864 - $223,844	7,504 New	7,504 $131,000
Q3 2020 Nov 09, 2020	SELL	$12.39 - $26.15 $55,321 - $116,759	-4,465 Closed	0 $0
Q2 2020 Jul 20, 2020	BUY	$14.59 - $36.07 $65,144 - $161,052	4,465 New	4,465 $122,000

38.7M

7.7K

Ticker PASG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,463,200
Market Cap $35.9M
Description
Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 ...

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg Americas Securities, LLC with notifications on news.